쿠에타핀 중단 후 전신통증을 동반한 불면을 호소하는 환자에 대한 길초근단 치험 1례
A Case of Insomnia with Pain after Discontinuation of Quetiapine Treated with Gilchogeun-dan
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: This case report describes an 82-year-old man complaining of insomnia with pain after discontinuation of quetiapine. Methods: The patient was treated with the herbal extraction Gilchogeun-dan, and symptomatic improvement was assessed using the Korean version of the Pittsburgh Sleep Quality Index. Results: Following 28 days of Gilchogeun-dan treatment, the patient’s symptoms improved. Conclusions: This case suggests that Gilchogeun-dan could be effective in treating insomnia with pain through central nervous depressant activity and analgesic effect.
Abstract
Objective: This case report describes an 82-year-old man complaining of insomnia with pain after discontinuation of quetiapine. Methods: The patient was treated with the herbal extraction Gilchogeun-dan, and symptomatic improvement was assessed using the Korean version of the Pittsburgh Sleep Quality Index. Results: Following 28 days of Gilchogeun-dan treatment, the patient’s symptoms improved. Conclusions: This case suggests that Gilchogeun-dan could be effective in treating insomnia with pain through central nervous depressant activity and analgesic effect.
참고문헌 (23)
- Choi HY, "Current Clinical Practice of Insomnia", Ewha Med J, 36(2), pp.84~92 (2013)
- Factor SA, "Sleep Disorders and Sleep Effect in Parkinson’s Disease", Mov Disord, 5(4), pp.280~285 (1990)
- 안태범, "파킨슨병 환자의 수면장애와 수면 관련 증상", 대한신경과학회지, 20(4), pp.365~372 (2002), 대한신경과학회
- Jahan I, "Sleep disorders in Parkinson’s disease", Neuropsychiatric Disease and Treatment, 5, pp.535~540 (2009)
- Leeman AL, "Parkinson’s disease in the elderly : response to and optimal spacing of night time dosing with levodopa", Br J Clin Pharmacol, 24(5), pp.637~643 (1987)
- Stocchi F, "Sleep disorders in Parkinson’s disease", J Neurol, 245(1), pp.S15~S18 (1998)
- Medeiros CA, "Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease. A randomized, double blind, placebo-controlled study", J Neurol, 254(4), pp.459~464 (2007)
- Carlos Juri, "Quetiapine for Insomnia in Parkinson Disease, Results From an Open-Label Trial", Clin Neuropharmacol, 28(4), pp.185~ (2005)
- Monaca C, "Effects of bilateral subthalamic stimulation on sleep in Parkinson’s disease", J Neurol, 251(2), pp.214~218 (2004)
- Lin CH, "Quetiapineinduced hepatocellular damage", Psychosomatics, 53(6), pp.601~602 (2012)
- NemeroffCB, "Quetiapine : preclinical studies, pharmacokinetics, drug interactions, and dosing", J Clin Psychiatry, 63(13), pp.5~1 (2002)
- 신승화, "한국어판 피츠버그 수면의 질 지수(PSQI-K) 도구의 신뢰도와 타당도 검증", 융합정보논문지, 10(11), pp.148~155 (2020), 중소기업융합학회[DOI]
- 서종근, "특발성 파킨슨병에서 수면의 질, 우울감, 삶의 질 사이의 상호 관계", Journal of sleep medicine, 11(1), pp.11~15 (2014), 대한수면연구학회
- Chaudhuri KR, "International multicentre pilot study of the first comprehensive self-completed non motor symptoms questionnaire for Parkinson’s disease : the NMSQuest study", Mov Disord, 21(7), pp.916~923 (2006)
- Roychowdhury S, "Sleep disturbance in Parkinson disease", Journal of Clinical Gerontology & Geriatrics, 3(2), pp.53~61 (2012)
- Terzano MG, "New Drugs for Insomnia : Comparative Tolerability of Zopiclone, Zolpidem and Zaleplon", Drug Safety, 26(4), pp.261~282 (2003)
- 이시진, "국역본초강목" (1976), 행림출판사
- 박선미, "纈草根 메탄올 추출물이 고지혈증 유발 생쥐의 지질대사에 미치는 영향", 한방비만학회지, 20(2), pp.88~96 (2020), 한방비만학회[DOI]
- Ross SM, "Sleep Disorders : A Single Dose Administration of Valerian", Hops Fluid Extract(Dormeasan)is Found to be Effective in Improving Sleep, 2009, pp.23(4), 253~256
- Leuschner J, "Characterisation of the central nervous depressant activity of a commercially available valerian root extract", Arzneimittelforschung, 43(6), pp.638~641 (1993)
- Zare A, "Analgesic Effect of Valerian Root and Turnip Extracts", World J Plast Surg, 7(3), pp.345~350 (2018)
- 박혜주, "불면증 무작위배정 임상시험에 대한 문헌 고찰", 동의신경정신과학회지, 24(3), pp.201~210 (2013), 대한한방신경정신과학회
- Monahan K, "Quetiapine withdrawal : A systematic review", Australian & New Zealand Journal of Psychiatry, 55(8), pp.772~783 (2021)